SRTA Stock Analysis: Buy, Sell, or Hold?
SRTA - Strata Critical Medical, Inc. Class A Common Stock
$6.24
0.28 (4.70%)
▲
5d:
+5.76%
30d:
+22.59%
90d:
+7.59%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 04, 2026
0d
Get Alerted When SRTA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: SRTA shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: SRTA shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: SRTA is currently trading at $6.24, which is considered extended relative to its 30-day fair value range of $5.08 to $5.89. From a valuation perspective, the stock is trading at a premium (Forward PE: 1784.8) compared to its historical average (62.4). At these levels, the market is pricing in 205.8% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, SRTA is in a uptrend. The price is approaching resistance at $6.29. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.7% recently.
Market Sentiment: SRTA scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $9.56 (+62.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SRTA is in a uptrend. The price is approaching resistance at $6.29. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.7% recently.
Market Sentiment: SRTA scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $9.56 (+62.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$5.08 -
$5.89
Company Quality Score
31/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
23.8%
All Signals
- BEARISH: Price extended above range (+5.9% above its trading range)
- BEARISH: Weak technical setup (5/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.7%)
- BULLISH: Trading 62.4% below Wall St target ($9.56)
- BEARISH: Market expects 205.8% growth - appears too optimistic based on history
- WARNING: Composite score 31/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$5.08 -
$5.89
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$5.68
Resistance Level
$6.29
Current Trend
Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
1784.85
Wall Street Target
$9.56
(+62.4%)
Revenue Growth (YoY)
60.7%
Profit Margin
15.7%
Valuation Premium vs History
+205.8% premium
PE vs Historical
1784.9 vs 62.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+205.8%
(market-implied from PE analysis)
1-Year Target
$8.83
(+50%)
2-Year Target
$13.25
(+125%)
3-Year Target
$19.88
(+238%)
3-Yr Target (if PE normalizes)
(PE: 1785→62)
PE COMPRESSION
$0.69
(-88%)
Significant PE compression expected
Share & Embed Analysis
Last updated: August 24, 2026 6:16 AM ET
Data refreshes hourly during market hours. Next update: 7:16 AM
Data refreshes hourly during market hours. Next update: 7:16 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SRTA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$282 | 37 SELL |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$451 | 44 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 47 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 42 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$135 | 54 HOLD |